On September 16th, the NHSA offically issued the “Guidelines on Establishing a Evaluating System of Drug Pricing and Bidding and Procurement Performence,” which stipulates that each province should establish and launch their own system before the end of 2020. The “Guidelines” clarifies that centralised procurement organizations of drugs and medical equipments should prevent pharmaceutical companies from fixing unreasonable drug price, such as via giving kickback to hospitals. At the meantime, the pharmaceutical companies that do not act properly will be documented and punished according to different levels of dishonesty while they are also encouraged to rectify to regain their credit score.
医保局：医药价格和招采信用评价年底前落地！
来源：医药网 2020.09.17
9月16日，国家医保局官网正式发布了《关于建立医药价格和招采信用评价制度的指导意见》（以下简称《意见》），要求各地于2020年底前建立并实施医药价格和招采信用评价制度。《意见》明确，药品和医用耗材集中采购机构应采取措施制止医药企业给予回扣等不合理定价行为。同时，应记录失信医药企业信息，根据不同失信等级采取不同处置措施，并鼓励企业整改，主动修复信用。
Leave a Reply